Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers
Authors:
- Akira InabaAIAkira Inaba
- Tetsuji UchiyamaTUTetsuji Uchiyama
- Shoichi HazamaSHShoichi Hazama
- Kouji ShimodaKSKouji Shimoda
- Michinari SuzukiMSMichinari Suzuki
- Takashi SuzukiTSTakashi Suzuki
- 1 February 1994
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 167 (2) , 264-267
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancerDiseases of the Colon & Rectum, 1990
- Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasisCellular Immunology, 1986
- Prostaglandins in breast cancer: Relationship to disease stage and hormone statusBritish Journal of Cancer, 1983
- Prostaglandins and human lung carcinomasBritish Journal of Cancer, 1982
- Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patientsJournal of Cancer Research and Clinical Oncology, 1981
- Prostaglandin modulation of development of cell-mediated immunity in cultureNature, 1980
- Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.Journal of Experimental Medicine, 1977
- Prostaglandins from tumours of human large bowelBritish Journal of Cancer, 1977
- Inactivation of Prostaglandins by the LungsNature, 1970
- PROSTAGLANDIN SECRETION BY MEDULLARY CARCINOMA OF THE THYROIDThe Lancet, 1968